These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7043962)

  • 21. [The development of biochip to detect anti-cholera antibodies in human blood serum].
    Utkin DV; Osina NA; Spitsin AN; Kireev MN; Gromova OV; Zakharova TL; Naidenova EV; Kuklev VE
    Klin Lab Diagn; 2015 Feb; 60(2):50-3. PubMed ID: 26027261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation among the Vibrio cholerae serotypes O1, O139, O141 and non-O1, non-O139, non-O141 using specific monoclonal antibodies with dot blotting.
    Pengsuk C; Longyant S; Rukpratanporn S; Chaivisuthangkura P; Sridulyakul P; Sithigorngul P
    J Microbiol Methods; 2011 Nov; 87(2):224-33. PubMed ID: 21851839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-O1 Vibrio cholerae and epidemic cholera.
    Commun Dis Rep CDR Wkly; 1993 Jun; 3(24):107. PubMed ID: 7693194
    [No Abstract]   [Full Text] [Related]  

  • 24. Nonlipopolysaccharide protective antigens shared by classical and El Tor biotypes of Vibrio cholerae.
    Sharma DP; Attridge S; Hackett J; Rowley D
    J Infect Dis; 1987 Apr; 155(4):716-23. PubMed ID: 3819476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cross-reaction between a strain of Vibrio mimicus and V. cholerae O139 Bengal.
    Ansaruzzaman M; Shimada T; Bhuiyan NA; Nahar S; Alam K; Islam MS; Albert MJ
    J Med Microbiol; 1999 Sep; 48(9):873-877. PubMed ID: 10482300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A monoclonal antibody-based study of the antigenic interrelations of typical and R forms of Vibrio cholerae].
    Alekseeva LP; Cherepakhina IIa; Sal'nikova OI; Burlakova OS
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (4):9-12. PubMed ID: 9783389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variation in epitopes of the B subunit of El Tor and classical biotype Vibrio cholerae O1 cholera toxin.
    Tamplin ML; Ahmed MK; Jalali R; Colwell RR
    J Gen Microbiol; 1989 May; 135(5):1195-200. PubMed ID: 2482860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Serologic response in man to cholera vaccine].
    Di Tommaso I
    Ann Sclavo; 1973; 15(4):445-52. PubMed ID: 4788453
    [No Abstract]   [Full Text] [Related]  

  • 29. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serological reactivity of humans to a Vibrio cholerae common antigen.
    Sciortino CV
    Curr Microbiol; 1998 Apr; 36(4):196-201. PubMed ID: 9537749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapid effects of a protective O-polysaccharide-specific monoclonal IgA on Vibrio cholerae agglutination, motility, and surface morphology.
    Levinson KJ; De Jesus M; Mantis NJ
    Infect Immun; 2015 Apr; 83(4):1674-83. PubMed ID: 25667263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vibrio cholerae flagellar antigens: a serodiagnostic test, functional implications of H-reactivity and taxonomic importance of cross-reactions within the Vibrio genus.
    Bhattacharyya FK
    Med Microbiol Immunol; 1975 Dec; 162(1):29-41. PubMed ID: 55952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A bioserogroup of marine vibrios possessing somatic antigen factors in common with Vibrio cholerae O1.
    Shimada T; Sakazaki R; Oue M
    J Appl Bacteriol; 1987 May; 62(5):453-6. PubMed ID: 3610890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enzyme-linked immunosorbent assay for determination of antibodies to Vibrio cholerae toxin-coregulated pili.
    Osek J; Jonson G; Svennerholm AM; Holmgren J
    APMIS; 1992 Nov; 100(11):1027-32. PubMed ID: 1361754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basic criteria and classification scheme for bacteriophages acting against cholera vibrios of the classical and El Tor biotypes.
    Bystryi NF; Drozhevkina MS
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(1):85-94. PubMed ID: 574886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody cross-reactions with lipopolysaccharide from E. coli O157 after cholera vaccination.
    Chart H; Rowe B
    Lancet; 1993 May; 341(8855):1282. PubMed ID: 8098423
    [No Abstract]   [Full Text] [Related]  

  • 37. [The characteristics of the protectiveness of a preparation of Vibrio cholerae outer membrane based on the data from a study using the ligated intestinal loop].
    Urbanovich LIa; Sappo SG; Kolesnik RS; Golubinskiĭ EP; Markov EIu; Ganin VS; Ivanova TA
    Zh Mikrobiol Epidemiol Immunobiol; 1997; (2):43-6. PubMed ID: 9245140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of a Vibrio cholerae 18-kDa antigen in vibrios.
    Sciortino CV
    FEMS Microbiol Lett; 1993 Jul; 111(1):49-55. PubMed ID: 8359680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the phenol-induced flagellar agglutination test for the identification of the cholera group of vibrios.
    Pastoris MC; Bhattacharyya FK; Sil J
    J Med Microbiol; 1980 May; 13(2):362-7. PubMed ID: 7381922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Vibrio cholerae classical TcpA amino acid sequence induces protective antibody that binds an area hypothesized to be important for toxin-coregulated pilus structure.
    Taylor RK; Kirn TJ; Meeks MD; Wade TK; Wade WF
    Infect Immun; 2004 Oct; 72(10):6050-60. PubMed ID: 15385509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.